BioSpace News Archive

Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide virtually painless and precise injections, announced that it has signed agreements with US Dental Depot and IQ Dental Supply for its Wand® Single Tooth Anesthesia System.

Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today the Neovasc Reducer™ (“Reducer”) was prominently featured in three peer reviewed European Journals.

Sun Nuclear Corporation announced that Ogaki Municipal Hospital has selected a collection of Sun Nuclear solutions for its end-to-end Radiation Therapy Quality Assurance program.

Veteran physician executive Mimi Huizinga brings a deep understanding of the role novel data plays in treatment development and delivery

The VHL Alliance announced the 2021 recipients of the VHLA Competitive Research Grant Program.

Omeros Corporation (Nasdaq: OMER) announced today that the Biologics License Application (BLA) for narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA) has been accepted for filing by the U.S. Food and Drug Administration (FDA)

Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today provided an update on the expansion of its intellectual property portfolio in 2020.

Icentia Inc., a leading Canadian technology company—specialised in cardiac ambulatory monitoring—will be providing a new home-based service nationwide that will enable patients with heart rhythm disorders to have access to an ambulatory cardiac test from the safety of their homes while the pandemic surges on.

Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, announced that senior leadership plans to present at the following virtual healthcare conferences

SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Kathy L. Hibbs was nominated to the company’s Board of Directors and its Audit Committee